| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Azab Mohammad serves as a Director at LSTA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 5 buys and 1 sell. Those positions are worth an estimated $731K at current prices.
The biggest single holding is XENE (~$731K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 31,312 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2019 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 23 | $9.31 | $214.18 | - | |
| Nov 15, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 15,000 | $2.22 | $33,280.50 | +51.4% | |
| Sep 22, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 10,000 | $2.95 | $29,500.00 | +52.1% | |
| Aug 18, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 6,335 | $2.90 | $18,362.59 | +49.2% |